Tenders/Lease and successive supply of medicinal product - HUMAN NORMAL IMMUNOGLOBULIN SUBCUTANEOUS
Awarded🇵🇱PolandSupplies

Lease and successive supply of medicinal product - HUMAN NORMAL IMMUNOGLOBULIN SUBCUTANEOUS

Auto-translated from Polish
Original title: Zakup i sukcesywna dostawa produktu leczniczego - IMMUNOGLOBULINUM HUMANUM NORMALE SUBCUTANEUM
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Published: Aug 11, 2026
Updated: Aug 24, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 4.7 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
Quality requirements for medicinal products are defined in the Act of September 6, 2001 - Pharmaceutical Law (consolidated text, Journal of Laws of 2016, item 2142, as amended), which in Article 1, paragraph 1, point 1, states that it defines, among others, the rules and procedures for placing medicinal products on the market, taking into account in particular the requirements for their quality, efficacy, and safety of use. Furthermore, the Regulation of the Minister of Health of November 9, 2015, on Good Manufacturing Practice requirements (Journal of Laws 2015, item 1979) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the present proceedings, the quality standard for medicinal products has been defined by the Contracting Authority by specifying in the description of the subject of the contract, which includes, among others: composition, dosage form, and route of administration, and unit of measure.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on August 11, 2026. Last refreshed 86 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji has issued 133 procurement notices on BidsFactory, including 7 currently open and 50 awarded contracts. Activity concentrates in Health & Medical, Construction & Civil Works, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 18, 2026.

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji: buyer profile, tenders and awards

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Takeda Pharma Sp. z o.o.; Urtica Sp. z o.o.; Lek S.A.; AstraZeneca Kereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság; Amgen Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Takeda Pharma Sp. z o.o.; Urtica Sp. z o.o.; Lek S.A.; AstraZeneca Kereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság; Amgen Sp. z o.o. was awarded the contract for PLN 35,186,863. The figure reflects the value disclosed by the contracting authority in the award notice.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Estimated Budget
PLN 4,685,200
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
🇵🇱Poland